BM0025
BMS-538305 L-(+)-tartrate
≥98% (HPLC)
别名:
(1S,5R)-2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane L-(+)-Tartaric acid salt, (2S)-2-Amino-1-(1S,5R)-2-azabicyclo[3.1.0]hex-2-yl-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-ethanone L-(+)-Tartaric acid salt, BMS 538305 tartarate, BMS-538305-06
assay
≥98% (HPLC)
form
powder
technique(s)
inhibition assay: suitable
color
white to beige
solubility
H2O: 20 mg/mL, clear
shipped in
ambient
storage temp.
room temp
General description
BMS-538305 is a saxagliptin analogue, without a nitrile group.
Biochem/physiol Actions
BMS-538305, a saxagliptin analog, is a potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor.
BMS-538305 is a potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor.
Features and Benefits
BMS-538305 is available through a partnership with Bristol-Myers Squibb (BMS). To learn more and view other BMS compounds, visit sigma.com/BMS.
Legal Information
Sold for research purposes only under agreement from BMS.
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Involvement of DPP-IV catalytic residues in enzyme?saxagliptin complex formation.
Melzier, W.J., et al.
Protein Science, 17(2), 240-250 (2008)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持